Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]

ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE

Dr Neal Shore and Prof Kim Chi

ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE ( Dr Neal Shore and Prof Kim Chi )

An AI-derived digital pathology-based biomarker to predict the benefit of ADT...

Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )

Survival outcomes of unilateral RB based on pathological risk stratification...

Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research...

Survival outcomes of unilateral RB based on pathological risk stratification-experience at a tertiary care centre in Pakistan ( Dr Palwasha Rehman - Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan )

NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion

Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA

NMIBC treated with IL-15RαFc superagonist N-803 and BCG infusion ( Prof Sam Chang - Vanderbilt University School of Medicine, Nashville, USA )

Latest developments in mHSPC

Prof Kurt Miller and Prof Laura-Maria Krabbe

Latest developments in mHSPC ( Prof Kurt Miller and Prof Laura-Maria Krabbe )

ASCO GU 2022: The latest in CRPC, including PARP combo data

Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel...

ASCO GU 2022: The latest in CRPC, including PARP combo data ( Prof Eleni Efstathiou, Prof Gerhardt Attard, Prof Noel Clarke and Prof Axel Merseburger )

Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma...

Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The...

Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis ( Dr Hielke Martijn de Vries - Netherlands Cancer Institute, Amsterdam, The Netherlands )

Tailoring radiation therapy in the 21st century

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Tailoring radiation therapy in the 21st century ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL

Dr Juliana Pereira & Dr Steven Horwitz

Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL ( Dr Juliana Pereira & Dr Steven Horwitz )

International Society of Paediatric Surgical Oncology (IPSO) surgical practice...

Dr Jaime Shalkow - National Institute of Paediatrics, Mexico City, Mexico

International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines ( Dr Jaime Shalkow - National Institute of Paediatrics, Mexico City, Mexico )

PET scanning in patients with classical Hodgkin lymphoma outside of Europe and...

Prof Mark Hertzberg - University of New South Wales, Sydney, Australia

PET scanning in patients with classical Hodgkin lymphoma outside of Europe and North America ( Prof Mark Hertzberg - University of New South Wales, Sydney, Australia )

Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in...

Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona...

Update: Cabozantinib plus nivolumab demonstrates continued survival benefit in aRCC ( Dr Cristina Suárez - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )

More from ecancer